Buspirone hydrochloride
- Product NDC
- 77771-235
- 11-digit product format
- 777710235
- Labeler code
- 77771
- Product ID
- 77771-235_3f66a40c-b9b2-06d4-e063-6294a90a9dda
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buspirone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Radha Pharmaceuticals, Inc.
- Application
- ANDA202087
- Marketing category
- ANDA
- Marketing start
- 2025-09-18
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 7.5 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202087-001 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2015-12-16 | |
| A202087-002 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2015-12-16 | |
| A202087-003 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2015-12-16 | |
| A202087-004 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2015-12-16 | |
| A202087-005 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2025-07-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202087-001 | AB |
| A202087-002 | AB |
| A202087-003 | AB |
| A202087-004 | AB |
| A202087-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202087-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2015-12-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202087-002 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2015-12-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202087-003 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2015-12-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202087-004 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2015-12-16 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202087-005 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2025-07-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202087-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202087-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202087-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202087-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202087-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | AiPing Pharmaceutical, Inc. | 55810b17-4796-49d0-90e4-8e075d62eda4 | 2026-07-29 | Warnings, Adverse reactions | 202087 ANDA202087 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 7b222cb0-0061-4a3e-9d0f-e9f120e7f5d9 | 2026-07-24 | Warnings, Adverse reactions | 202087 ANDA202087 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 427ad27e-6664-afee-e063-6394a90a1890 | 2026-01-08 | Warnings, Adverse reactions | 202087 ANDA202087 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 45c637b7-3057-ea38-e063-6394a90a87b6 | 2025-12-12 | Warnings, Adverse reactions | 202087 ANDA202087 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 424d81f0-b195-5bc2-e063-6394a90a2104 | 2025-12-10 | Warnings, Adverse reactions | 202087 ANDA202087 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 3f66a3fe-9d73-180c-e063-6394a90aacca | 2025-09-22 | Warnings, Adverse reactions | 202087 ANDA202087 77771-235 |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | EPIC PHARMA, LLC | e8f43c66-f8de-419f-9ea9-43ddc4ec0798 | 2025-01-07 | Warnings, Adverse reactions | 202087 ANDA202087 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Buspirone hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUSPIRONE HYDROCHLORIDE | 7.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 207LT9J9OC | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3f66a3fe-9d73-180c-e063-6394a90aacca | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a9968269-ddf2-400e-9170-7376dcf3545a | Product name | 1 | 20251215 |
| 2cf3c2e9-d566-c982-009a-188fe4f776b9 | Product name | 8 | 20200428 |
| 4a9096ce-7b98-89e5-5942-15f48c4f7abf | Product name | 5 | 20190711 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 77771-235-01 | Buspirone hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 77771-235-01 | EA - Each | 77771-235 | 141ea349-ac48-46aa-960f-0319edee8246 | 1 | 2025-10-14 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 866083 | busPIRone HCl 10 MG Oral Tablet | PSN | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866018 | busPIRone HCl 15 MG Oral Tablet | PSN | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866090 | busPIRone HCl 30 MG Oral Tablet | PSN | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866094 | busPIRone HCl 5 MG Oral Tablet | PSN | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866111 | busPIRone HCl 7.5 MG Oral Tablet | PSN | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866083 | buspirone hydrochloride 10 MG Oral Tablet | SCD | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866018 | buspirone hydrochloride 15 MG Oral Tablet | SCD | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866090 | buspirone hydrochloride 30 MG Oral Tablet | SCD | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866094 | buspirone hydrochloride 5 MG Oral Tablet | SCD | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866111 | buspirone hydrochloride 7.5 MG Oral Tablet | SCD | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866083 | buspirone HCl 10 MG (buspirone 9.1 MG) Oral Tablet | SY | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866111 | buspirone HCl 7.5 MG (buspirone 6.9 MG) Oral Tablet | SY | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866018 | buspirone hydrochloride 15 MG (buspirone 13.7 MG) Oral Tablet | SY | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866090 | buspirone hydrochloride 30 MG (buspirone 27.4 MG) Oral Tablet | SY | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
| 866094 | buspirone hydrochloride 5 MG (buspirone 4.6 MG) Oral Tablet | SY | 3f66a3fe-9d73-180c-e063-6394a90aacca | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 77771-235-01 | 77771023501 | 100 TABLET in 1 BOTTLE (77771-235-01) | 100 tablet | 2025-09-18 | No | No | Current |